Merck & Co., Inc. (MRK) PE Ratio: 33.37
Is Merck & Co., Inc.’s P/E ratio high or low?
Merck & Co., Inc.'s P/E ratio of 33.37 is 49% below its 5-year average of 65.31, near the low end of its 5-year range (10.69–942.50).
The P/E ratio for Merck & Co., Inc. (MRK) is 33.37 as of Wednesday, June 10, 2026. It is above its 12-month average by 111.35% (15.79).
PE Ratio (33.37) = Close Price ($118.47) / Diluted TTM EPS ($3.55)
MRK PE Ratio Chart
MRK Average PE Ratio Chart
MRK Current vs Average PE Ratio Chart
MRK PE Ratio Metrics
PE RATIO
33.37
PE RATIO AVG TTM
15.79
PE RATIO AVG 3Y
94.46
PE RATIO AVG 5Y
65.31
PE RATIO AVG 10Y
51.03
PE RATIO AVG 15Y
42.42
PE RATIO AVG 20Y
36.60
CURRENT VS TTM AVG
+111.35%
CURRENT VS 3Y AVG
-64.67%
CURRENT VS 5Y AVG
-48.91%
CURRENT VS 10Y AVG
-34.60%
CURRENT VS 15Y AVG
-21.33%
CURRENT VS 20Y AVG
-8.82%
MRK Competitors' PE Ratio
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Merck & Co., Inc. (MRK) | — | 33.37 | 15.79 | 94.46 | 65.31 |
| UnitedHealth Group Incorporated (UNH) | $368.44B | 30.69 | 17.88 | 24.47 | 25.24 |
| AbbVie Inc. (ABBV) | $399.54B | 110.80 | 116.32 | 75.54 | 55.71 |
| Amgen Inc. (AMGN) | $183.75B | 23.67 | 25.06 | 29.63 | 26.36 |
| Thermo Fisher Scientific Inc. (TMO) | $179.45B | 26.55 | 29.20 | 32.54 | 31.18 |
| Abbott Laboratories (ABT) | $154.66B | 24.74 | 19.30 | 27.88 | 28.20 |
| Gilead Sciences, Inc. (GILD) | $151.21B | 16.58 | 21.34 | 157.50 | 110.62 |
| Intuitive Surgical, Inc. (ISRG) | $146.44B | 50.15 | 65.94 | 75.04 | 71.85 |
| Pfizer Inc. (PFE) | $146.36B | 19.58 | 16.36 | 22.40 | 18.18 |
| Danaher Corporation (DHR) | $130.25B | 35.67 | 41.62 | 38.62 | 34.94 |
P/E vs. its own history
At 33.4, P/E is richer than usual — richer than 82% of its 20-year range.
20-year low
5.3
median
21.4
20-year high
942.5
P/E Comparison
Trailing P/E
33.4
Forward P/E
12.3
Forward P/E Calculation
View All Analyst EstimatesForward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$118.47
Forward EPS (Est.)
$9.64
Forward P/E
12.29
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
Merck & Co., Inc. PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Merck & Co., Inc. PE Ratio FAQ
- What is the P/E ratio for Merck & Co., Inc. (MRK)?
- The P/E ratio for MRK stock is 33.37.
- Is Merck & Co., Inc.'s P/E ratio high or low?
- Merck & Co., Inc.'s P/E ratio of 33.37 is 49% below its 5-year average of 65.31, near the low end of its 5-year range (10.69–942.50).
- What is the TTM average P/E ratio for Merck & Co., Inc. (MRK)?
- The TTM average P/E ratio for MRK stock is 15.79.
- What is the 3Y average P/E ratio for Merck & Co., Inc. (MRK)?
- The 3Y average P/E ratio for MRK stock is 94.46.
- What is the 5Y average P/E ratio for Merck & Co., Inc. (MRK)?
- The 5Y average P/E ratio for MRK stock is 65.31.
- What is the 10Y average P/E ratio for Merck & Co., Inc. (MRK)?
- The 10Y average P/E ratio for MRK stock is 51.03.
- What is the 15Y average P/E ratio for Merck & Co., Inc. (MRK)?
- The 15Y average P/E ratio for MRK stock is 42.42.
- What is the 20Y average P/E ratio for Merck & Co., Inc. (MRK)?
- The 20Y average P/E ratio for MRK stock is 36.60.
Merck & Co., Inc. PE Ratio History
| DATE | PE RATIO |
|---|---|
| 2026-06-10 | 33.37 |
| 2026-06-09 | 33.69 |
| 2026-06-08 | 33.67 |
| 2026-06-05 | 34.03 |
| 2026-06-04 | 33.88 |
| 2026-06-03 | 32.31 |
| 2026-06-02 | 32.58 |
| 2026-06-01 | 32.44 |
| 2026-05-29 | 33.44 |
| 2026-05-28 | 33.77 |
| 2026-05-27 | 33.87 |
| 2026-05-26 | 33.72 |
| 2026-05-22 | 34.48 |
| 2026-05-21 | 32.64 |
| 2026-05-20 | 31.83 |
| 2026-05-19 | 32.18 |
| 2026-05-18 | 31.71 |
| 2026-05-15 | 31.37 |
| 2026-05-14 | 31.95 |
| 2026-05-13 | 31.96 |
| 2026-05-12 | 31.65 |
| 2026-05-11 | 31.35 |
| 2026-05-08 | 31.37 |
| 2026-05-07 | 31.63 |
| 2026-05-06 | 31.99 |
| 2026-05-05 | 31.87 |
| 2026-05-04 | 31.86 |
| 2026-05-01 | 15.41 |
| 2026-04-30 | 15.00 |
| 2026-04-29 | 15.24 |
| 2026-04-28 | 15.11 |
| 2026-04-27 | 15.14 |
| 2026-04-24 | 15.37 |
| 2026-04-23 | 15.74 |
| 2026-04-22 | 15.51 |
| 2026-04-21 | 15.46 |
| 2026-04-20 | 16.09 |
| 2026-04-17 | 16.36 |
| 2026-04-16 | 15.86 |
| 2026-04-15 | 16.20 |
| 2026-04-14 | 16.48 |
| 2026-04-13 | 16.50 |
| 2026-04-10 | 16.68 |
| 2026-04-09 | 16.85 |
| 2026-04-08 | 16.92 |
| 2026-04-07 | 16.38 |
| 2026-04-06 | 16.60 |
| 2026-04-02 | 16.60 |
| 2026-04-01 | 16.60 |
| 2026-03-31 | 16.52 |
| 2026-03-30 | 16.22 |
| 2026-03-27 | 16.43 |
| 2026-03-26 | 16.34 |
| 2026-03-25 | 16.40 |
| 2026-03-24 | 15.98 |
| 2026-03-23 | 15.89 |
| 2026-03-20 | 15.68 |
| 2026-03-19 | 15.69 |
| 2026-03-18 | 15.73 |
| 2026-03-17 | 15.92 |
| 2026-03-16 | 15.86 |
| 2026-03-13 | 15.88 |
| 2026-03-12 | 15.92 |
| 2026-03-11 | 15.96 |
| 2026-03-10 | 16.08 |
| 2026-03-09 | 16.09 |
| 2026-03-06 | 15.91 |
| 2026-03-05 | 15.94 |
| 2026-03-04 | 16.52 |
| 2026-03-03 | 16.46 |
| 2026-03-02 | 16.68 |
| 2026-02-27 | 17.01 |
| 2026-02-26 | 16.39 |
| 2026-02-25 | 16.82 |
| 2026-02-24 | 17.02 |
| 2026-02-23 | 16.36 |
| 2026-02-20 | 16.15 |
| 2026-02-19 | 16.10 |
| 2026-02-18 | 16.07 |
| 2026-02-17 | 16.06 |
| 2026-02-13 | 16.04 |
| 2026-02-12 | 15.75 |
| 2026-02-11 | 15.75 |
| 2026-02-10 | 15.48 |
| 2026-02-09 | 15.54 |
| 2026-02-06 | 16.11 |
| 2026-02-05 | 15.82 |
| 2026-02-04 | 15.63 |
| 2026-02-03 | 15.30 |
| 2026-02-02 | 14.98 |
| 2026-01-30 | 14.57 |
| 2026-01-29 | 14.31 |
| 2026-01-28 | 14.12 |
| 2026-01-27 | 14.26 |
| 2026-01-26 | 14.19 |
| 2026-01-23 | 14.29 |
| 2026-01-22 | 14.42 |
| 2026-01-21 | 14.68 |
| 2026-01-20 | 14.46 |
| 2026-01-16 | 14.38 |
| 2026-01-15 | 14.66 |
| 2026-01-14 | 14.66 |
| 2026-01-13 | 14.30 |
| 2026-01-12 | 14.42 |
| 2026-01-09 | 14.60 |
| 2026-01-08 | 14.66 |
| 2026-01-07 | 14.35 |
| 2026-01-06 | 14.38 |
| 2026-01-05 | 14.19 |
| 2026-01-02 | 14.06 |
| 2025-12-31 | 13.90 |
| 2025-12-30 | 14.01 |
| 2025-12-29 | 14.08 |
| 2025-12-26 | 14.11 |
| 2025-12-24 | 14.06 |
| 2025-12-23 | 13.88 |
| 2025-12-22 | 13.83 |
| 2025-12-19 | 13.35 |
| 2025-12-18 | 13.30 |
| 2025-12-17 | 13.10 |
| 2025-12-16 | 12.98 |
| 2025-12-15 | 13.24 |
| 2025-12-12 | 13.25 |
| 2025-12-11 | 13.08 |
| 2025-12-10 | 12.90 |
| 2025-12-09 | 12.80 |
| 2025-12-08 | 13.07 |
| 2025-12-05 | 13.17 |
| 2025-12-04 | 13.33 |
| 2025-12-03 | 13.51 |
| 2025-12-02 | 13.35 |
| 2025-12-01 | 13.45 |
| 2025-11-28 | 13.85 |
| 2025-11-26 | 13.82 |
| 2025-11-25 | 13.96 |
| 2025-11-24 | 13.26 |
| 2025-11-21 | 12.91 |
| 2025-11-20 | 12.55 |
| 2025-11-19 | 12.56 |
| 2025-11-18 | 12.74 |
| 2025-11-17 | 12.27 |
| 2025-11-14 | 12.27 |
| 2025-11-13 | 12.28 |
| 2025-11-12 | 12.08 |
| 2025-11-11 | 12.01 |
| 2025-11-10 | 11.46 |
| 2025-11-07 | 11.40 |
| 2025-11-06 | 11.33 |
| 2025-11-05 | 11.15 |
| 2025-11-04 | 12.92 |
| 2025-11-03 | 12.71 |
| 2025-10-31 | 13.25 |
| 2025-10-30 | 13.29 |
| 2025-10-29 | 13.34 |
| 2025-10-28 | 13.41 |
| 2025-10-27 | 13.56 |
| 2025-10-24 | 13.48 |
| 2025-10-23 | 13.43 |
| 2025-10-22 | 13.50 |
| 2025-10-21 | 13.50 |
| 2025-10-20 | 13.30 |
| 2025-10-17 | 13.06 |
| 2025-10-16 | 12.93 |
| 2025-10-15 | 12.96 |
| 2025-10-14 | 13.05 |
| 2025-10-13 | 13.20 |
| 2025-10-10 | 13.25 |
| 2025-10-09 | 13.48 |
| 2025-10-08 | 13.31 |
| 2025-10-07 | 13.50 |
| 2025-10-06 | 13.68 |
| 2025-10-03 | 13.74 |
| 2025-10-02 | 13.79 |
| 2025-10-01 | 13.89 |
| 2025-09-30 | 12.93 |
| 2025-09-29 | 12.11 |
| 2025-09-26 | 12.10 |
| 2025-09-25 | 11.96 |
| 2025-09-24 | 12.28 |
| 2025-09-23 | 12.32 |
| 2025-09-22 | 12.39 |
| 2025-09-19 | 12.56 |
| 2025-09-18 | 12.56 |
| 2025-09-17 | 12.50 |
| 2025-09-16 | 12.49 |
| 2025-09-15 | 12.48 |
| 2025-09-12 | 12.76 |
| 2025-09-11 | 13.12 |
| 2025-09-10 | 12.95 |
| 2025-09-09 | 13.04 |
| 2025-09-08 | 12.96 |
| 2025-09-05 | 13.05 |
| 2025-09-04 | 12.95 |
| 2025-09-03 | 12.97 |
| 2025-09-02 | 13.17 |
| 2025-08-29 | 12.96 |
| 2025-08-28 | 12.82 |
| 2025-08-27 | 12.95 |
| 2025-08-26 | 13.10 |
| 2025-08-25 | 13.14 |
| 2025-08-22 | 13.46 |
| 2025-08-21 | 13.26 |
| 2025-08-20 | 13.04 |
| 2025-08-19 | 13.09 |
| 2025-08-18 | 12.98 |
| 2025-08-15 | 12.98 |
| 2025-08-14 | 12.75 |
| 2025-08-13 | 12.74 |
| 2025-08-12 | 12.37 |
| 2025-08-11 | 12.33 |
| 2025-08-08 | 12.43 |
| 2025-08-07 | 12.38 |
| 2025-08-06 | 12.24 |
| 2025-08-05 | 12.45 |
| 2025-08-04 | 11.62 |
| 2025-08-01 | 11.54 |
| 2025-07-31 | 11.37 |
| 2025-07-30 | 11.90 |
| 2025-07-29 | 12.03 |
| 2025-07-28 | 12.24 |
| 2025-07-25 | 12.33 |
| 2025-07-24 | 12.24 |
| 2025-07-23 | 12.22 |
| 2025-07-22 | 11.88 |
| 2025-07-21 | 11.54 |
| 2025-07-18 | 11.64 |
| 2025-07-17 | 11.87 |
| 2025-07-16 | 12.00 |
| 2025-07-15 | 11.87 |
| 2025-07-14 | 12.18 |
| 2025-07-11 | 12.13 |
| 2025-07-10 | 12.23 |
| 2025-07-09 | 12.18 |
| 2025-07-08 | 11.84 |
| 2025-07-07 | 11.78 |
| 2025-07-03 | 11.78 |
| 2025-07-02 | 11.99 |
| 2025-07-01 | 11.91 |
| 2025-06-30 | 11.52 |
| 2025-06-27 | 11.51 |
| 2025-06-26 | 11.47 |
| 2025-06-25 | 11.60 |
| 2025-06-24 | 11.69 |
| 2025-06-23 | 11.67 |
| 2025-06-20 | 11.51 |
| 2025-06-18 | 11.54 |
| 2025-06-17 | 11.39 |
| 2025-06-16 | 11.78 |
| 2025-06-13 | 11.89 |
| 2025-06-12 | 11.91 |
| 2025-06-11 | 11.69 |
| 2025-06-10 | 11.84 |
| 2025-06-09 | 11.55 |
| 2025-06-06 | 11.49 |
| 2025-06-05 | 11.30 |
| 2025-06-04 | 11.39 |
| 2025-06-03 | 11.23 |
| 2025-06-02 | 11.10 |
| 2025-05-30 | 11.18 |
| 2025-05-29 | 11.12 |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Robert Davis